Australia now at BioJapan 2018
BioJapan (held alongside Regenerative Medicine Japan) will celebrate its 20th anniversary in 2018. The event has been a critical platform for industry and academic experts in the drug discovery, personalised medicine, regenerative medicine and diagnostics sectors.
In 2017, BioJapan had over 900 exhibitors and attracted more than 15,000 visitors to the conference which is regarded as the biggest international conference in this field in Asia.
Austrade will coordinate Australia’s presence at BioJapan 2018. In conjunction with AusBiotech, the Australian Government aims to increase awareness of Australia’s Life Sciences sector, high quality research capabilities, and position Australia’s biotech expertise to Japanese and international audiences. The aim is to enhance further collaboration between Australia and Japanese life sciences and medical research communities.
Our involvement is sponsored by DFAT’s Australia now program to showcase Australia in Japan in 2018
Trade mission detailsWhat types of businesses should attend?
Australian organisations involved in human therapeutics,drug development, clinical trials services providers and CROs, regenerative medicine and cell therapies, pharmaceuticals, and medical research are encouraged to apply.